Advertisement

Management of stroke as described by Ibn Sina (Avicenna) in the Canon of Medicine

  • Arman Zargaran
    Correspondence
    Corresponding author at: Research Office for the History of Persian Medicine, North Ghaani Street, Shiraz, Iran. Tel.: +98 9122060881.
    Affiliations
    Student Research Committee, Department of History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

    Department of Traditional Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
    Search for articles by this author
  • Mohammad M. Zarshenas
    Affiliations
    Department of Traditional Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

    Research Office for the History of Persian Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
    Search for articles by this author
  • Aliasghar Karimi
    Affiliations
    Student Research Committee, Department of History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
    Search for articles by this author
  • Hassan Yarmohammadi
    Affiliations
    Student Research Committee, Department of History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

    Research Office for the History of Persian Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
    Search for articles by this author
  • Afshin Borhani-Haghighi
    Affiliations
    Department of Neurology, Shiraz University of Medical Sciences, Shiraz, Iran

    Traditional Medicine and History of Medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
    Search for articles by this author
Published:September 23, 2013DOI:https://doi.org/10.1016/j.ijcard.2013.08.115

      Abstract

      Stroke or cerebrovascular accident (CVA) is caused by a disturbance of the blood supply to the brain and an accruing loss of brain function. The first recorded observations were in 2455 BC and it has been studied intensely by ancient physicians throughout history. In the early medieval period, Ibn Sina (980–1025 AD) called stroke sekteh and described it extensively. Some of Ibn Sina's definitions and his etiology of stroke are based on humoral theories and cannot be compared with medical current concepts, but most of his descriptions concur with current definitions. This review examines the definition and etiology, clinical manifestations, prognosis, differential diagnosis, and interventions for stroke based on Ibn Sina's epic work, Canon of Medicine. The pharmacological effects of medicinal herbs suggested by Ibn Sina for stroke are examined in light of current knowledge.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sims N.R.
        • Muyderman H.
        Mitochondria, oxidative metabolism and cell death in stroke.
        Biochim Biophys Acta. 2010; 1802: 80-91
        • Cameron V.
        Best practices for stroke patient and family education in the acute care setting: a literature review.
        Medsurg Nurs. 2013; 22 ([64]): 51-55
        • Shahtaheri R.A.
        • Borhani Haghighi A.
        • Safari A.
        • Cruz-Flores S.
        Recombinant tissue plasminogen activator (rtPA) and stroke unit for acute ischaemic stroke in developing countries, are they cost-effective?.
        Int J Stroke. 2012; 7: E9
        • Borhani Haghighi A.
        • Karimi A.A.
        • Amiri A.
        • Ghaffarpasand F.
        Knowledge and attitude towards stroke risk factors, warning symptoms and treatment in an Iranian population.
        Med Princ Pract. 2010; 19: 468-472
        • Borhani-Haghighi A.
        • Safari R.
        • Heydari S.T.
        • Soleimani F.
        • Sharifian M.
        • Yektaparast-Kashkuli S.
        Hospital mortality associated with stroke in Southern Iran.
        Iran J Med Sci. 2013;
        • Abolhassani H.
        • Naseri M.
        • Mahmoudzadeh S.
        A survey of complementary and alternative medicine in Iran.
        Chin J Integr Med. 2012; 18: 409-416
        • Zarshenas M.M.
        • Hosseinkhani A.
        • Zargaran A.
        • Kordafshari G.
        • Mohagheghzadeh A.
        Ophthalmic dosage forms in medieval Persia.
        Pharm Hist (Lond). 2013; 43: 6-8
        • Zargaran A.
        • Zarshenas M.M.
        • Mehdizadeh A.
        • Mohagheghzadeh A.
        Oxymel in medieval Persia.
        Pharm Hist (Lond). 2012; 42: 11-13
        • Ahmad S.
        • Rehman S.
        • Ahmad A.M.
        • et al.
        Khamiras, a natural cardiac tonic: an overview.
        J Pharm Bioallied Sci. 2010; 2: 93-99
        • Jackson W.A.
        A short guide to humoral medicine.
        Trends Pharmacol Sci. 2001; 22: 487-489
        • Zargaran A.
        • Mehdizadeh A.
        • Zarshenas M.M.
        • Mohagheghzadeh A.
        Avicenna (980–1037 AD).
        J Neurol. 2012; 259: 389-390
        • Zarshenas M.M.
        • Zargaran A.
        • Abolhassanzadeh Z.
        • Vessal K.
        Jorjani (1042–1137).
        J Neurol. 2012; 259: 2764-2765
        • Zarshenas M.M.
        • Mehdizadeh A.
        • Zargaran A.
        • Mohagheghzadeh A.
        Rhazes (865–925 AD).
        J Neurol. 2012; 259: 1001-1002
        • Karimi A.
        • Zargaran A.
        • Borhani-Haghighi A.
        Avicenna's description of Willis circle.
        Int J Cardiol. 2013; 168: 3041
        • York III, G.K.
        • Steinberg D.A.
        Chapter 3: neurology in ancient Egypt.
        Handb Clin Neurol. 2010; 95: 29-36
        • Ashrafian H.
        Familial stroke 2700 years ago.
        Stroke. 2010; 41: e187
        • Nilsen M.L.
        A historical account of stroke and the evolution of nursing care for stroke patients.
        J Neurosci Nurs. 2010; 42: 19-27
        • O'Collins V.E.
        • Donnan G.A.
        • Howells D.W.
        History of animal models of stroke.
        Int J Stroke. 2011; 6: 77-78
        • Karenberg A.
        Reconstructing a doctrine: Galen on apoplexy.
        J Hist Neurosci. 1994; 3: 85-101
        • Wang Y.
        • Fan Y.C.
        • Xie C.L.
        • Zheng G.Q.
        History of post-stroke epilepsy in ancient China.
        J Neurol. 2011; 258: 1555-1558
        • Karenberg A.
        • Hort I.
        Medieval description and doctrines of stroke: preliminary analysis of select sources. Part I: the struggles for terms and theories—Late Antiquity and Early Middle Ages (300–800).
        J Hist Neurosci. 1998; 7: 162-173
        • Zargaran A.
        • Zarshenas M.M.
        • Ahmadi S.A.
        • Vessal K.
        Haly Abbas (949–982 AD).
        J Neurol. 2013; 260: 2196-2197
        • Nejabat M.
        • Maleki B.
        • Nimrouzi M.
        • Mahbodi A.
        • Salehi A.
        Avicenna and cataracts: a new analysis of contributions to diagnosis and treatment from the canon.
        Iran Red Crescent Med J. 2012; 14: 265-270
        • Choopani R.
        • Mosaddegh M.
        • Gir A.A.
        • Emtiazy M.
        Avicenna (Ibn Sina) aspect of atherosclerosis.
        Int J Cardiol. 2012; 156: 330
        • Celik T.
        Time to remember Avicenna for his contribution to pulsology.
        Int J Cardiol. 2010; 144: 446
        • Shoja M.M.
        • Tubbs R.S.
        • Loukas M.
        • Khalili M.
        • Alakbarli F.
        • Cohen-Gadol A.A.
        Vasovagal syncope in the Canon of Avicenna: the first mention of carotid artery hypersensitivity.
        Int J Cardiol. 2009; 134: 297-301
        • Zargaran A.
        • Zarshenas M.M.
        • Mehdizadeh A.
        • Kordafshari G.
        • Mohagheghzadeh A.
        Avicenna's concept of cardiovascular drug targeting in Medicamenta Cordialia.
        Res Hist Med. 2013; 2: 11-14
        • Abokrysha N.
        Ibn Sina (Avicenna) on pathogenesis of migraine compared with the recent theories.
        Headache. 2009; 49: 923-927
        • Resende L.A.
        • Weber S.
        Peripheral facial palsy in the past: contributions from Avicenna, Nicolaus Friedreich and Charles Bell.
        Arq Neuropsiquiatr. 2008; 66: 765-769
        • Zargaran A.
        • Zarshenas M.M.
        • Mehdizadeh A.
        • Mohagheghzadeh A.
        Management of tremor in medieval Persia.
        J Hist Neurosci. 2013; 22: 53-61
        • Turgut O.
        • Manduz S.
        • Tandogan I.
        Avicenna: messages from a great pioneer of ancient medicine for modern cardiology.
        Int J Cardiol. 2010; 145: 222
        • Faridi P.
        • Zarshenas M.M.
        Ibn Sina's book on drugs for cardiovascular diseases.
        Int J Cardiol. 2010; 145: 223
        • Zareshenas M.M.
        • Abolhassanzadeh Z.
        • Faridi P.
        • Mohagheghzadeh A.
        Ibn Sina's treaties on pulsology.
        Int J Cardiol. 2011; 146: 243-244
        • Nathan B.
        Avicenna on the causes and signs of stroke.
        J Stroke Cerebrovasc Dis. 1992; 2: 85-86
      1. Sharafkandi A. [Translator], The Persian translation of Qanoun fi al-Tibb (or the Canon of Medicine). Tehran: Soroush Press; 1987.

        • Ibn Sina A.A.H.
        al-Din I.S. Al-Qanon fi al-Tibb. Alamy Le-Al-Matbooat Institute, Lebanon2005
        • Emtiazy M.
        • Choopani R.
        • Khodadoost M.
        • Tansaz M.
        • Nazem E.
        Atheroprotector role of the spleen based on the teaching of Avicenna (Ibn Sina).
        Int J Cardiol. 2013; 167 ([15]): 26-28
        • Naseri M.
        The review on Iranian traditional medicine.
        Nashr Shahr, Tehran2007: 15-49
        • Darbandi S.
        • Darbandi M.
        • Mokarram P.
        • et al.
        Effects of body electroacupuncture on plasma leptin concentrations in obese and overweight people in Iran: a randomized controlled trial.
        Altern Ther Health Med. 2013; 19: 24-31
        • Kale S.P.
        • Edgell R.C.
        • Alshekhlee A.
        • et al.
        Age-associated vasospasm in aneurysmal subarachnoid hemorrhage.
        J Stroke Cerebrovasc Dis. 2013; 22: 22-27
        • Divani A.A.
        • Zantek N.D.
        • Borhani-Haghighi A.
        • Rao G.H.
        Antiplatelet therapy: aspirin resistance and all that jazz!.
        Clin Appl Thromb Hemost. 2013; 19: 5-18
        • Shyu Y.S.
        • Lin J.T.
        • Chang Y.T.
        • Chiang C.J.
        • Yang D.J.
        Evaluation of antioxidant ability of ethanolic extract from dill (Anethum graveolens L.) flower.
        Food Chem. 2009; 115: 515-521
        • Mighria H.
        • Hajlaouib H.
        • Akrouta A.
        • Najjaaa H.
        • Neffati M.
        Antimicrobial and antioxidant activities of Artemisia herba-alba essential oil cultivated in Tunisian arid zone.
        C R Chim. 2010; 13: 380-386
        • Pyo Y.H.
        • Lee T.C.
        • Logendra L.
        • Rosen R.T.
        Antioxidant activity and phenolic compounds of Swiss chard (Beta vulgaris subspecies cycla) extracts.
        Food Chem. 2004; 85: 19-26
        • Pavlov A.
        • Kovatcheva P.
        • Tuneva D.
        • Ilieva M.
        • Bley T.
        Radical scavenging activity and stability of betalains from Beta vulgaris hairy root culture in simulated conditions of human gastrointestinal tract.
        Plant Foods Hum Nutr. 2005; 60: 43-47
        • Hwang S.L.
        • Shih P.H.
        • Yen G.C.
        Neuroprotective effects of citrus flavonoids.
        J Agric Food Chem. 2012; 60: 877-885
        • Singh G.
        • Kiran S.
        • Marimuthu P.
        • Isidorov V.
        • Vinogorova V.
        Antioxidant and antimicrobial activities of essential oil and various oleoresins of Elettaria cardamomum (seeds and pods).
        J Sci Food Agric. 2008; 88: 280-289
        • Verma S.K.
        • Jain V.
        • Katewa S.S.
        Blood pressure lowering, fibrinolysis enhancing and antioxidant activities of cardamom (Elettaria cardamomum).
        Indian J Biochem Biophys. 2009; 46: 503-506
        • Ghanbari M.
        • Khorasani M.Z.
        • Vakili A.
        • Taherian A.A.
        • Sameni H.R.
        Acute and chronic effects of aqueous Ferula persica extract on blood pressure of normotensive rats.
        J Koomesh. 2012; 14: 104-108
        • Fernández-López J.
        • Sevilla L.
        • Sayas-Barberá E.
        • Navarro C.
        • Marín F.
        • Pérez-Alvarez J.A.
        Evaluation of the antioxidant potential of hyssop (Hyssopus officinalis L.) and rosemary (Rosmarinus officinalis L.) extracts in cooked pork meat.
        J Food Sci. 2003; 68: 660-664
        • Katsarou A.
        • Rhizopoulou S.
        • Kefalas P.
        Antioxidant potential of the aerial tissues of the mistletoe Loranthus europaeus Jacq.
        Rec Nat Prod. 2012; 6: 394-397
        • Chandrashekhar V.M.
        • Ranpariya V.L.
        • Ganapaty S.
        • Parashar A.
        • Muchandi A.A.
        Neuroprotective activity of Matricaria recutita Linn against global model of ischemia in rats.
        J Ethnopharmacol. 2010; 127: 645-651
        • Cemek M.
        • Kağa S.
        • Simşek N.
        • Büyükokuroğlu M.E.
        • Konuk M.
        Antihyperglycemic and antioxidative potential of Matricaria chamomilla L. in streptozotocin-induced diabetic rats.
        J Natl Med. 2008; 62: 284-293
        • El-Ghorab A.H.
        The chemical composition of the Mentha pulegium L. essential oil from Egypt and its antioxidant activity.
        J Essent Oil Bear Plants. 2006; 9: 183-195
        • Chatterjeea S.
        • Niaza Z.
        • Gautama S.
        • Adhikarib S.
        • Variyara P.S.
        • Sharmaa A.
        Antioxidant activity of some phenolic constituents from green pepper (Piper nigrum L.) and fresh nutmeg mace (Myristica fragrans).
        Food Chem. 2007; 101: 515-523
        • Jin Jun W.
        • Kyung Han B.
        • Won Yu K.
        • Sung Kim M.
        • Yon Cho H.
        Antioxidant effects of Origanum majorana L. on superoxide anion radicals.
        Food Chem. 2001; 75: 439-444
        • Yazdanparast R.
        • Shahriyary L.
        Comparative effects of Artemisia dracunculus, Satureja hortensis and Origanum majorana on inhibition of blood platelet adhesion, aggregation and secretion.
        Vascul Pharmacol. 2008; 48: 32-37
        • Raafat K.M.
        • Jassar H.
        • Aboul-Ela M.
        • El-Lakany A.
        Protective effects of Origanum majorana L. against neurodegeneration: fingerprinting, isolation and in vivo glycine receptors behavioral model.
        Int J Phytomed. 2013; 5https://doi.org/10.5138/ijpm.v5i1.996
        • Subramanian U.
        • Poongavanam S.
        • Vanisree A.J.
        Studies on the neuroprotective role of Piper longum in C6 glioma induced rats.
        Invest New Drugs. 2010; 28: 615-623
        • Gülçin İ.
        The antioxidant and radical scavenging activities of black pepper (Piper nigrum) seeds.
        Int J Food Sci Nutr. 2005; 56: 491-499
        • Gardeli C.
        • Vassiliki P.
        • Athanasios M.
        • Kibouris T.
        • Komaitis M.
        Essential oil composition of Pistacia lentiscus L. and Myrtus communis L.: evaluation of antioxidant capacity of methanolic extracts.
        Food Chem. 2008; 107: 1120-1130
        • Mansouri S.M.T.
        • Naghizadeh B.
        • Hosseinzadeh H.
        The effect of Pistacia vera L. gum extract on oxidative damage during experimental cerebral ischemia–reperfusion in rats.
        Iran Biomed J. 2005; 9: 181-185
        • Çoruh N.
        • Celep A.G.
        • Özgökçe F.
        Antioxidant properties of Prangos ferulacea (L.) Lindl., Chaerophyllum macropodum Boiss. and Heracleum persicum Desf. from Apiaceae family used as food in Eastern Anatolia and their inhibitory effects on glutathione-S-transferase.
        Food Chem. 2007; 100: 1237-1242
        • Bozan B.
        • Kosar M.
        • Tunalier Z.
        • Ozturk N.
        Antioxidant and free radical scavenging activities of Rhus coriaria and Cinnamomum cassia extracts.
        Acta Aliment. 2003; 32: 53-61
        • Achuthan C.R.
        • Babu B.H.
        • Padikkala J.
        Antioxidant and hepatoprotective effects of Rosa damascena.
        Pharm Biol. 2003; 41: 357-361
        • Senol F.S.
        • Orhan I.
        • Kürkçüoğlu M.
        • et al.
        An in vitro approach to neuroprotective activity of Rosa damascena Mill., a medieval age traditional medicine used for memory enhancement.
        Planta Med. 2013; 77: 163-164
        • Abdel-Wahhab M.A.
        • Aly S.E.
        Antioxidant property of Nigella sativa (black cumin) and Syzygium aromaticum (clove) in rats during aflatoxicosis.
        J Appl Toxicol. 2005; 25: 218-223
        • Sharififar F.
        • Moshafi M.H.
        • Mansouri S.H.
        • Khodashenas M.
        • Khoshnoodi M.
        In vitro evaluation of antibacterial and antioxidant activities of the essential oil and methanol extract of endemic Zataria multiflora Boiss.
        Food Control. 2007; 18: 800-805
        • Sharififar F.
        • Derakhshanfar A.
        • Dehghan-Nudeh G.
        • et al.
        In vivo antioxidant activity of Zataria multiflora Boiss essential oil.
        Pak J Pharm Sci. 2011; 24: 221-225
        • Ghayur M.N.
        • Gilani A.H.
        Ginger lowers blood pressure through blockade of voltage-dependent calcium channels.
        J Cardiovasc Pharmacol. 2005; 45: 74-80
        • Guh J.H.
        • Ko F.N.
        • Jong T.T.
        • Teng C.M.
        Antiplatelet effect of gingerol isolated from Zingiber officinale.
        J Pharm Pharmacol. 1995; 47: 329-332
        • Stoilova I.
        • Krastanov A.
        • Stoyanova A.
        • Denev P.
        • Gargova S.
        Antioxidant activity of a ginger extract (Zingiber officinale).
        Food Chem. 2007; 102: 764-770
        • Tuekpe M.K.
        • Todoriki H.
        • Sasaki S.
        • Zheng K.C.
        • Ariizumi M.
        Potassium excretion in healthy Japanese women was increased by a dietary intervention utilizing home-parcel delivery of Okinawan vegetables.
        Hypertens Res. 2006; 29: 389-396
        • Cassidy A.
        • Rimm E.B.
        • O'Reilly E.J.
        • et al.
        Dietary flavonoids and risk of stroke in women.
        Stroke. 2012; 43: 946-951
        • Mizrahi A.
        • Knekt P.
        • Montonen J.
        • Laaksonen M.A.
        • Heliövaara M.
        • Järvinen R.
        Plant foods and the risk of cerebrovascular diseases: a potential protection of fruit consumption.
        Br J Nutr. 2009; 102: 1075-1083
        • Yamada T.
        • Hayasaka S.
        • Shibata Y.
        • et al.
        Frequency of citrus fruit intake is associated with the incidence of cardiovascular disease: the Jichi Medical School cohort study.
        J Epidemiol. 2011; 21: 169-175
        • Chang T.T.
        • Chen K.C.
        • Chang K.W.
        • et al.
        In silico pharmacology suggests ginger extracts may reduce stroke risks.
        Mol Biosyst. 2011; 7: 2702-2710
        • Jittiwat J.
        • Wattanathorn J.
        Ginger pharmacopuncture improves cognitive impairment and oxidative stress following cerebral ischemia.
        J Acupunct Meridian Stud. 2012; 5: 295-300
        • Feng X.G.
        • Hao W.J.
        • Ding Z.
        • Sui Q.
        • Guo H.
        • Fu J.
        Clinical study on tongyan spray for post-stroke dysphagia patients: a randomized controlled trial.
        Chin J Integr Med. 2012; 18: 345-349